Physician profile
Ebony N Parson
NPI 1588950729
$2,786.02
in general payments reported to CMS, 2019-2025
27 companies · $475 in 2025
The $475 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $202 · 2021: $88.53 · 2022: $361 · 2023: $540 · 2024: $622 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $545.50 | 2019-2025 | |
| Astellas Pharma US INC | $313.17 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $215.18 | 2022-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $188.54 | 2023-2025 | Myfembree |
| Channel Medsystems, INC. | $148.83 | 2025 | |
| Pfizer INC. | $145.02 | 2019-2024 | |
| Gynesonics, INC. | $137.01 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $124.99 | 2022 | |
| Mayne Pharma Commercial LLC | $111.14 | 2023-2025 | |
| Lupin INC. | $99.29 | 2019 | |
| Daiichi Sankyo INC. | $96.17 | 2019-2025 | Injectafer |
| Therapeuticsmd, INC. | $94.27 | 2019-2020 | |
| Exeltis, USA INC. | $88.20 | 2019-2025 | Slynd |
| Organon LLC | $69.33 | 2024-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $66.88 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $64.06 | 2024 | |
| Coopersurgical, INC. | $57.06 | 2024 | Paragard T 380a |
| Shield Therapeutics INC | $35.19 | 2023-2024 | Accrufer |
| Siemens Medical Solutions USA, INC. | $30.81 | 2025 | Acuson Sequoia Diagnostic Ultrasound System |
| Exact Sciences Corporation | $28.48 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $27.73 | 2023-2024 | |
| Millicent US INC | $23.20 | 2024 | Intrarosa, Femring |
| Currax Pharmaceuticals LLC | $17.24 | 2025 | Contrave |
| Ethicon US, LLC | $16.61 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.53 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.62 | 2019 | |
| Allergan, INC. | $12.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebony Parson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.